Management of Pain in Pancreatic Cancer

Initial Pain Management

The American Society of Clinical Oncology (ASCO) recommends that initial pain management may involve non-opioid medications, including acetaminophen, for patients with pancreatic cancer 1, 2
The American Society of Clinical Oncology (ASCO) suggests that acetaminophen can be used as a first-line analgesic for mild to moderate pain in patients with pancreatic cancer 1, 2

The National Comprehensive Cancer Network (NCCN) recommends a maximum daily dose of 4000 mg (4 grams) of acetaminophen per day for patients with cancer 3
The National Comprehensive Cancer Network (NCCN) suggests limiting the daily dose of acetaminophen to 3000 mg or less for chronic administration in patients with cancer 3
The maximum single dose of acetaminophen is 1000 mg (1 gram) 4

The American Society of Clinical Oncology (ASCO) recommends considering the addition of adjuvant analgesics (gabapentin, pregabalin, nortriptyline, duloxetine) for patients with pancreatic cancer who experience neuropathic pain 1, 2
The National Comprehensive Cancer Network (NCCN) recommends that patients with pancreatic cancer who are 60 years or older may require a reduced daily dose of acetaminophen, to 3000 mg or less 3
Patients with pre-existing liver disease can safely use acetaminophen at doses of 2-3 g/day, even those with cirrhosis 4

For patients with mild pain, start with acetaminophen (up to 3000 mg/day for chronic administration) 1, 2, 3
For patients with moderate pain, add weak opioids (tramadol) or continue acetaminophen with titration 1, 2
For patients with severe pain, use strong opioids (morphine, fentanyl), with morphine generally being the drug of choice, preferred oral route 5, 6
For patients with refractory pain, consider celiac plexus block by neurolysis, particularly for those who tolerate opioids poorly 1, 5, 6